Guan, W
What they're saying: According to the lawsuit, one of the plaintiffs switched from Zepbound to Wegovy in August after exhausting all appeals to Caremark, then "experienced a number of side effects, including the return of his Gastroesophageal Reflux Disease, stomach pain, hunger, and, most notably, weight gain." "Because of their different methods of action, different clinical outcomes, and different side effects for individual patients, Zepbound and Wegovy are not clinically interchangeable," the lawsuit states
201204 ALDH2 can inhibit the activation of NLRP3 inflammasome by reducing the excessive accumulation of mitochondrial ROS (mtROS) and total intracellular ROS, thereby mitigating high glucose-induced pyroptosis in cardiomyocytes
Patients in these states frequently ask about workarounds, but there are none
New Program Medical Weight Management Program A physician-supervised weight loss program that combines weekly clinical visits, personalized nutrition coaching, and FDA-approved GLP-1 medications for safe, lasting results
2020 May 1;78(5):394-411